Pantoprazole Gastro Resistand and Domperidone Prolonged Release Capsules IP

About Pantoprazole Gastro Resistand and Domperidone Prolonged Release Capsules IP

A combination medication containing:

• Rabeprazole Sodium (Enteric Coated) a proton pump inhibitor (PPI) that reduces stomach acid secretion, helping heal and prevent acid-related gastrointestinal disorders.

• Domperidone (Sustained Release) a prokinetic agent that promotes gastric emptying and helps relieve nausea and vomiting.

This combination is commonly used to manage acid reflux, GERD, dyspepsia, and gastric motility disorders.

Typical Composition (per capsule):

Uses / Indications:

• Gastroesophageal reflux disease (GERD)

• Peptic ulcers

• Functional dyspepsia

• Gastritis and acid-related stomach disorders

• Nausea and vomiting associated with delayed gastric emptying

• Prevention of nausea caused by acid-lowering therapy

Dosage & Administration:

Swallow whole; do not crush or chew.
Take consistently at the same time each day.

Precautions:

• Use cautiously in patients with:

  • Liver impairment

  • Prolonged QT interval or cardiac arrhythmias (due to Domperidone)

  • Electrolyte imbalances

• Avoid use in children below 12 years (dose adjustments may be necessary)

• Inform physician about any other medications, especially those affecting heart rhythm

Possible Side Effects:

Drug Interactions:

• Rabeprazole may reduce absorption of drugs requiring acidic environment (e.g., ketoconazole)

• Domperidone risk increased with QT-prolonging drugs (e.g., some antibiotics, antipsychotics)

• Avoid concurrent use with other prokinetics without medical advice

Storage:

• Store at room temperature below 25C

• Keep capsules in original packaging to protect from moisture

• Keep out of reach of children